Testing for Chlamydia in Women
Author Information
Author(s): Mark B. Reedy, Patricia J. Sulak, William B. McCombs III, Thomas J. Kuehl
Primary Institution: Scott & White Clinic and Memorial Hospital Texas A&M University College of Medicine
Hypothesis
How does the Syva Direct Fluorescent Antibody Assay perform compared to tissue culture in a low-prevalence population?
Conclusion
The Syva DFA assay lacks the sensitivity and positive predictive value for routine use in Ob/Gyn populations with a low prevalence of C. trachomatis.
Supporting Evidence
- The prevalence of chlamydia in the tested population was found to be 7.7%.
- The DFA assay demonstrated a sensitivity of 80% and a specificity of 97%.
- The positive predictive value of the DFA assay was 72%, indicating a significant number of false positives.
- Less than 3% of the specimens were considered inadequate for testing.
- 19 false positives and 12 false negatives were identified in the study.
Takeaway
This study looked at a test for chlamydia and found it doesn't work well in women who are less likely to have the infection.
Methodology
Endocervical specimens were collected from women at risk for chlamydia infection and tested using the Syva DFA assay and tissue culture.
Potential Biases
Potential bias due to the low prevalence of chlamydia in the study population.
Limitations
The study's results may not apply to high-prevalence populations, and the DFA assay may yield false positives.
Participant Demographics
Women at risk for chlamydia infection, including those with multiple sex partners, new sex partners, sexually active adolescents, and pregnant women.
Want to read the original?
Access the complete publication on the publisher's website